Manufacturer profile
Cell Marque Corporation
Saudi Arabia·635 devices635
Total Devices
2
Risk Classes
2020
Earliest Expiry
Recent products (latest 10)
Most recently added devices in the database
| Product Name | Risk Class | Detail |
|---|---|---|
| Cadherin 17(SP183) Rabbit Monoclonal Primary antibody | General IVD(Others) | View |
| CD16 (SP175) | Class I | View |
| TCL1 (EP105) | Class I | View |
| Villin (CWWB1) | Class I | View |
| Caveolin-1 (2297) | Class I | View |
| CD7 (EP132) | Class I | View |
| Tryptase (EP259) | Class I | View |
| Transgelin (2A10C2) | Class I | View |
| TTF-1 (EP229) | Class I | View |
| Cytokeratin 14 (SP53) | Class I | View |
Risk class distribution
Breakdown by risk classification
Class I
473(74.5%)
General IVD(Others)
162(25.5%)
About this profile
Explore comprehensive manufacturer profile for Cell Marque Corporation through Pure Global AI's free Saudi Arabia medical device database. This company manufactures 635 medical devices registered with SFDA across 2 risk classes.
This page provides detailed insights including recent registrations, risk class distribution (Class I: 473, General IVD(Others): 162), and complete regulatory information from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry.
Free Manufacturer ProfilePowered by Pure Global AI635 Devices2 Risk Classes